scholarly article | Q13442814 |
P356 | DOI | 10.1002/JCP.24448 |
P698 | PubMed publication ID | 23939952 |
P2093 | author name string | Chuck C-K Chao | |
Pu-Yuan Chang | |||
Nian-Kang Sun | |||
Zchong-Zcho Wu | |||
P2860 | cites work | Elk-1 a transcription factor with multiple facets in the brain | Q21129371 |
Cabin 1, a negative regulator for calcineurin signaling in T lymphocytes | Q24313056 | ||
Integration of calcineurin and MEF2 signals by the coactivator p300 during T-cell apoptosis | Q24599847 | ||
Deletion of calcineurin and myocyte enhancer factor 2 (MEF2) binding domain of Cabin1 results in enhanced cytokine gene expression in T cells | Q24674634 | ||
The calcineurin-binding protein cain is a negative regulator of synaptic vesicle endocytosis | Q28142953 | ||
Apoptosis of T cells mediated by Ca2+-induced release of the transcription factor MEF2 | Q28146018 | ||
The complexity of p53 modulation: emerging patterns from divergent signals | Q28284854 | ||
The Epstein-Barr virus transforming protein LMP1 engages signaling proteins for the tumor necrosis factor receptor family | Q28307399 | ||
Targeted inhibition of calcineurin prevents agonist-induced cardiomyocyte hypertrophy | Q28343890 | ||
Calpain-dependent cleavage of cain/cabin1 activates calcineurin to mediate calcium-triggered cell death | Q28564504 | ||
Cain, a novel physiologic protein inhibitor of calcineurin | Q28570296 | ||
Two-site interaction of nuclear factor of activated T cells with activated calcineurin | Q28616392 | ||
Cofactor dynamics and sufficiency in estrogen receptor-regulated transcription | Q29547846 | ||
Latent membrane protein 1 of Epstein-Barr virus interacts with JAK3 and activates STAT proteins | Q33891012 | ||
eIF-4E expression and its role in malignancies and metastases. | Q35750118 | ||
Calcineurin activity is required for the initiation of skeletal muscle differentiation | Q36327575 | ||
Epstein-Barr virus latent membrane protein 1 is essential for B-lymphocyte growth transformation | Q36575274 | ||
Phosphorylation and ubiquitination-dependent degradation of CABIN1 releases p53 for transactivation upon genotoxic stress | Q36619894 | ||
Living with p53, dying of p53. | Q36919156 | ||
Targeting the eukaryotic translation initiation factor 4E for cancer therapy | Q37075670 | ||
Cross-resistance to death ligand-induced apoptosis in cisplatin-selected HeLa cells associated with overexpression of DDB2 and subsequent induction of cFLIP. | Q38332168 | ||
Silencing of the SNARE protein NAPA sensitizes cancer cells to cisplatin by inducing ERK1/2 signaling, synoviolin ubiquitination and p53 accumulation | Q39477209 | ||
Knockdown of CITED2 using short-hairpin RNA sensitizes cancer cells to cisplatin through stabilization of p53 and enhancement of p53-dependent apoptosis | Q39527015 | ||
Knockdown of NAPA using short-hairpin RNA sensitizes cancer cells to cisplatin: implications to overcome chemoresistance | Q39676804 | ||
Cabin1 restrains p53 activity on chromatin. | Q39814358 | ||
Epstein-Barr virus-encoded latent membrane protein 1 promotes stress-induced apoptosis upstream of caspase-2-dependent mitochondrial perturbation | Q40509666 | ||
Epstein-Barr virus latent membrane protein 1 induces micronucleus formation, represses DNA repair and enhances sensitivity to DNA-damaging agents in human epithelial cells. | Q40600441 | ||
Apoptosis modulation of Epstein-Barr virus-encoded latent membrane protein 1 in the epithelial cell line HeLa is stimulus-dependent | Q40680566 | ||
Epstein-Barr virus latent membrane protein 1 (LMP1) activates the phosphatidylinositol 3-kinase/Akt pathway to promote cell survival and induce actin filament remodeling | Q40687983 | ||
Apaf-1 overexpression partially overcomes apoptotic resistance in a cisplatin-selected HeLa cell line | Q40779227 | ||
The Epstein-Barr virus latent membrane protein 1 (LMP1) enhances TNF alpha-induced apoptosis of intestine 407 epithelial cells: the role of LMP1 C-terminal activation regions 1 and 2. | Q40882594 | ||
Activation of a ras-MAPK-dependent pathway by Epstein-Barr virus latent membrane protein 1 is essential for cellular transformation | Q41068635 | ||
Epstein-Barr virus latent membrane protein inhibits human epithelial cell differentiation | Q41736955 | ||
Amino-terminal-derived JNK fragment alters expression and activity of c-Jun, ATF2, and p53 and increases H2O2-induced cell death | Q42803661 | ||
Latent membrane protein 1 of Epstein-Barr virus sensitizes cancer cells to cisplatin by enhancing NF-κB p50 homodimer formation and downregulating NAPA expression. | Q42805210 | ||
Three distinct signalling responses by murine fibroblasts to genotoxic stress | Q42807014 | ||
Identification and functional analysis of genes which confer resistance to cisplatin in tumor cells | Q43110995 | ||
Cisplatin induction of ERCC-1 mRNA expression in A2780/CP70 human ovarian cancer cells. | Q52184954 | ||
An EBV membrane protein expressed in immortalized lymphocytes transforms established rodent cells. | Q53541156 | ||
Three paths to stress relief | Q59054090 | ||
P433 | issue | 3 | |
P921 | main subject | genotoxicity | Q1009245 |
P304 | page(s) | 309-322 | |
P577 | publication date | 2014-03-01 | |
P1433 | published in | Journal of Cellular Physiology | Q1524270 |
P1476 | title | EBV-encoded LMP-1 sensitizes nasopharyngeal carcinoma cells to genotoxic drugs by down-regulating Cabin1 expression | |
P478 | volume | 229 |
Q35032548 | Epstein-Barr Virus_Encoded LMP1 upregulates microRNA-21 to promote the resistance of nasopharyngeal carcinoma cells to cisplatin-induced Apoptosis by suppressing PDCD4 and Fas-L. |
Q38633665 | JNK pathway inhibition enhances chemotherapeutic sensitivity to Adriamycin in nasopharyngeal carcinoma cells |
Q35990061 | Novel Biomarker Proteins in Chronic Lymphocytic Leukemia: Impact on Diagnosis, Prognosis and Treatment |
Q90687242 | iTRAQ-based quantitative proteomic analysis of differentially expressed proteins in chemoresistant nasopharyngeal carcinoma |